Endo International | ENDP - Spese Operative



Spese Operative Cambiamento Data
AbbVie USD 10.27B 538M 2026-03
Amarin USD 51.48M 113K 2025-12
ANI Pharmaceuticals USD 562.3M 344.37M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Coherus Biosciences USD 51.83M 2.48M 2025-12
Eli Lilly USD 10.02B 285M 2026-03
Heron Therapeutics USD 40.55M 1.46M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Ligand Pharmaceuticals USD 34.35M 5.27M 2026-03
Merck USD 18.17B 8.01B 2026-03
Novartis USD 9.29B 507M 2026-03
Pacira USD 172.75M 20.93M 2026-03
Perrigo USD 935.6M 89.6M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Supernus Pharmaceuticals USD 1.08B 879.06M 2026-03
Takeda JPY 1.11T 85.29B 2026-03
Teva Pharmaceutical Industries USD 3.22B 1000M 2026-03
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zoetis USD 3.23B 1.68B 2026-03